whether alpha blockers (Cardura, Hytrin, etc) are safe for treating hypertension
July 2001
A citizen's petition to add a warning to Cardura is renewing the controversy about whether alpha blockers (Cardura, Hytrin, etc) are safe for treating hypertension.
This stems from the National Institutes of Health's huge ALLHAT hypertension trial.
It suggests that patients on Cardura are TWICE as likely to be hospitalized for heart failure as those on chlorthalidone.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote